Sex-specific association between carotid atherosclerosis and fundus arteriosclerosis in a Chinese population: a

Chunxing Liu1, Xiaolong Yang2, Mengmeng Ji1

  • 1Department of Laboratory, Hua Dong Sanatorium, Wuxi, 214065, China.

PubMed

Insights

Fundus arteriosclerosis is linked to carotid atherosclerosis in the Chinese population. This association was significant in males but not observed in females, highlighting sex-based differences in vascular disease.

Area of Science:

  • Cardiovascular Medicine
  • Ophthalmology
  • Public Health

Background:

  • Vascular stiffening predicts adverse cardiovascular events.
  • The relationship between microangiopathy (fundus arteriosclerosis) and carotid atherosclerosis is unclear.
  • Investigating this link is crucial for understanding cardiovascular risk.

Purpose of the Study:

  • To examine the association between carotid atherosclerosis and fundus arteriosclerosis.
  • To explore potential sex differences in this relationship.
  • To analyze data from a large Chinese health-examination cohort.

Main Methods:

  • Retrospective cross-sectional study of 20,836 participants (13,050 males, 7786 females).
  • Fundus photography for fundus arteriosclerosis assessment.
  • Color Doppler sonography for carotid atherosclerosis diagnosis.
  • Binary logistic regression analysis.

Main Results:

  • Fundus arteriosclerosis was more prevalent in individuals with carotid atherosclerosis (52.94% vs. 47.06%).
  • Fundus arteriosclerosis showed a significant association with carotid atherosclerosis risk (OR 1.17; 95% CI 1.02-1.34).
  • This association was significant in males (p=0.0005) but not in females (p=0.0746).

Conclusions:

  • Fundus arteriosclerosis is closely associated with carotid atherosclerosis in the Chinese population.
  • The association between fundus and carotid arteriosclerosis differs between sexes.
  • Findings suggest sex-specific risk factors or pathways in vascular aging.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
15
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
10
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11